The active pharmaceutical ingredients (API) market size is expected to grow by $64.53B from 2020 to 2025, progressing at a CAGR of 6.1% according to the latest market research report by Technavio– with 66% of the market's growth originating from Asia-Pacific countries (APAC) during the forecast period. China, India, and Japan are the key markets for AP in APAC. Market growth in this region will be faster than the growth of the market in other regions. China accounts for the largest share in the API market in APAC. The Chinese pharmaceutical industry mainly produces basic chemicals and APIs. The major reason for China's ability to capture the global API market is the cheap and cost-effective production of APIs, resulting from its large-scale manufacturing, which will facilitate the active pharmaceutical ingredients (API) market growth in APAC over the forecast period.